ProShare Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$578K Sell
11,182
-1,882
-14% -$95.8K ﹤0.01% 994
2025
Q4
$649K Buy
13,064
+866
+7% +$42.1K ﹤0.01% 1000
2025
Q3
$583K Sell
12,198
-1,970
-14% -$79.3K ﹤0.01% 1028
2025
Q2
$447K Sell
14,168
-270
-2% -$8.65K ﹤0.01% 1182
2025
Q1
$473K Sell
14,438
-3,401
-19% -$121K ﹤0.01% 1128
2024
Q4
$645K Buy
17,839
+4,008
+29% +$141K ﹤0.01% 1130
2024
Q3
$431K Sell
13,831
-8,321
-38% -$260K ﹤0.01% 1223
2024
Q2
$593K Buy
22,152
+8,293
+60% +$240K ﹤0.01% 890
2024
Q1
$473K Buy
13,859
+1,021
+8% +$30.4K ﹤0.01% 1123
2023
Q4
$372K Buy
12,838
+1,669
+15% +$44.3K ﹤0.01% 1238
2023
Q3
$308K Sell
11,169
-170
-1% -$5.17K ﹤0.01% 1195
2023
Q2
$341K Buy
11,339
+277
+3% +$9.69K ﹤0.01% 1189
2023
Q1
$401K Sell
11,062
-1,367
-11% -$52.6K ﹤0.01% 1018
2022
Q4
$443K Buy
12,429
+1,068
+9% +$37.1K ﹤0.01% 1016
2022
Q3
$384K Buy
11,361
+164
+1% +$5.34K ﹤0.01% 1013
2022
Q2
$323K Sell
11,197
-5,370
-32% -$154K ﹤0.01% 1169
2022
Q1
$536K Sell
16,567
-3,295
-17% -$101K ﹤0.01% 1246
2021
Q4
$578K Buy
19,862
+843
+4% +$25.6K ﹤0.01% 1351
2021
Q3
$507K Sell
19,019
-4,694
-20% -$126K ﹤0.01% 1211
2021
Q2
$730K Buy
23,713
+1,822
+8% +$55.9K ﹤0.01% 1247
2021
Q1
$573K Buy
21,891
+1,944
+10% +$54.4K ﹤0.01% 1347
2020
Q4
$502K Buy
19,947
+4,529
+29% +$97.5K ﹤0.01% 1276
2020
Q3
$321K Sell
15,418
-486
-3% -$11K ﹤0.01% 1139
2020
Q2
$378K Buy
15,904
+4,942
+45% +$109K ﹤0.01% 1092
2020
Q1
$197K Sell
10,962
-8,504
-44% -$179K ﹤0.01% 1014
2019
Q4
$462K Sell
19,466
-1,675
-8% -$40.7K ﹤0.01% 1106
2019
Q3
$581K Sell
21,141
-838
-4% -$24.8K ﹤0.01% 927
2019
Q2
$727K Sell
21,979
-2,604
-11% -$89.2K ﹤0.01% 881
2019
Q1
$861K Buy
24,583
+246
+1% +$9.15K 0.01% 833
2018
Q4
$808K Sell
24,337
-4,265
-15% -$183K 0.01% 771
2018
Q3
$1.44M Sell
28,602
-1,286
-4% -$63.5K 0.01% 680
2018
Q2
$1.79M Sell
29,888
-1,585
-5% -$82.1K 0.01% 644
2018
Q1
$1.44M Sell
31,473
-4,871
-13% -$203K 0.01% 696
2017
Q4
$1.45M Buy
36,344
+3,542
+11% +$140K 0.01% 712
2017
Q3
$1.31M Buy
32,802
+2,055
+7% +$88.9K 0.01% 670
2017
Q2
$1.32M Sell
30,747
-2,572
-8% -$91.5K 0.01% 655
2017
Q1
$1.04M Sell
33,319
-8,025
-19% -$215K 0.01% 734
2016
Q4
$1.04M Buy
41,344
+3,836
+10% +$85.7K 0.01% 755
2016
Q3
$928K Sell
37,508
-5,792
-13% -$131K 0.01% 704
2016
Q2
$882K Buy
43,300
+2,096
+5% +$37.2K 0.01% 761
2016
Q1
$628K Sell
41,204
-3,992
-9% -$52.1K 0.01% 899
2015
Q4
$607K Buy
45,196
+4,332
+11% +$67K 0.01% 949
2015
Q3
$573K Sell
40,864
-2,153
-5% -$40K 0.01% 891
2015
Q2
$730K Buy
43,017
+2,774
+7% +$39.5K 0.01% 920
2015
Q1
$487K Buy
40,243
+5,524
+16% +$52.2K 0.01% 1185
2014
Q4
$288K Buy
34,719
+973
+3% +$8.18K ﹤0.01% 1547
2014
Q3
$293K Sell
33,746
-6,051
-15% -$54.7K ﹤0.01% 1734
2014
Q2
$436K Sell
39,797
-2,581
-6% -$23K 0.01% 1672
2014
Q1
$379K Buy
42,378
+26,327
+164% +$242K ﹤0.01% 2077
2013
Q4
$121K Sell
16,051
-4,220
-21% -$29.5K ﹤0.01% 1296
2013
Q3
$149K Buy
+20,271
New +$136K ﹤0.01% 2296

Other funds holding SUPN